About the Cancer
Currently Available Clinical Trials from Georgetown Lombardi
Use the link above to search for these suggested keywords:
– Lung cancer
More clinical trials are available on NIH’s national clinical trial database.
Monday – Friday,
8:30 am – 5:00 pm
You will be redirected to our clinical partner, MedStar Health.
Georgetown Lombardi Comprehensive Cancer Center is committed to providing you with the most current information and resources available on lung cancers. Learn more about lung cancer and the available treatments for it through our clinical partner, MedStar Health.
Additionally, current information about lung cancers (Non-Small Cell, Small Cell), incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials, and research is available online from the National Cancer Institute at the National Institutes of Health. See also Mesothelioma.
What We Offer
- Interdisciplinary Lung Cancer Clinic (ILC): The evaluation and management of lung cancer is complex, requiring a comprehensive approach with the involvement of experts from multiple specialties. It is exactly this multidisciplinary approach that the Georgetown Lombardi Comprehensive Cancer Center provides through its ILC.
- Patient and Family Resources
- Clinical Trials: Through our clinical partnership with MedStar Health, Georgetown Lombardi is pleased to offer you access to cutting-edge clinical trials.
- Faculty Experts
Lung cancer remains the leading cause of cancer deaths, accounting for nearly a third of all deaths due to cancer. It is imperative that we explore newer and better treatments for patients with lung cancer. Our robust research program within the Interdisciplinary Lung Cancer Clinic offers a wide range of clinical trials for patients with lung cancer, exploring novel therapeutics. Additionally, we are also performing studies to understand the biology of lung cancer, with an aim to develop strategies for early diagnosis and tailor therapies to the needs of individual patients.